Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling

The endocannabinoid 2-arachidonoylglycerol (2-AG) is predominantly metabolized by monoacylglycerol lipase (MAGL) in the brain. Selective inhibitors of MAGL provide valuable insights into the role of 2-AG in a variety of (patho)physiological processes and are potential therapeutics for the treatment...

Full description

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: Hui Deng, Qianwen Zhang, Qian Lei, Na Yang, Kai Yang, Jianbing Jiang, Zhiyi Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.941522/full

Similar Items